Financial Performance Summary

Consolidated Q2 FY27 Financial Highlights:

  • Total Revenue: INR 1,363.0 Cr (41.3% YoY growth, 14.0% QoQ growth)
  • Revenue from Operations: INR 1,344.4 Cr (39.9% YoY growth, 14.0% QoQ growth)
  • EBITDA (Pre-INDAS): INR 250.0 Cr (24.7% YoY growth, 12.7% QoQ growth)
  • EBITDA (Pre-INDAS and excluding Other Income): INR 231.6 Cr (17.9% YoY growth, 12.6% QoQ growth)
  • Reported EBITDA (Incl. other income): INR 278.9 Cr (34.0% YoY growth, 16.3% QoQ growth)
  • EBITDA Margin: 20.5% (vs. 20.1% in Q1 FY27 and 21.7% in Q2 FY26)
  • PAT: INR 76.0 Cr (vs. INR 37.0 Cr in Q1 FY27 and INR 72.0 Cr in Q2 FY26)
  • Consolidated EPS: INR 1.8 (8.5% YoY growth)
  • Cash and Cash Equivalents: INR 420.0 Cr as of 30th September 2026

Half-Year FY27 Financial Performance:

  • Total Income (H1): INR 2,558.9 Cr
  • Revenue from Operations (H1): INR 2,523.9 Cr

Comparative Financial Data Table:

| Particulars | Q2 FY27 | Q1 FY27 | Q2 FY26 | QoQ | YoY | FY26 | FY25 | YoY |

| Total Income (Cr) | 1,363.0 | 1,195.9 | 964.9 | 14.0% | 41.3% | 3,930.8 | 3,067.0 | |

| Other Income (Cr) | 18.6 | 16.4 | 4.2 | | | 26.2 | 31.9 | |

| Revenue from Operations (Cr) | 1,344.4 | 1,179.5 | 960.7 | 14.0% | 39.9% | 3,904.6 | 3,035.1 | 28.6% |

| PBT* (Cr) | 106.6 | 56.6 | 96.8 | 88.3% | 10.1% | 333.9 | 558.1 | -40.2% |

| Interest (Cr) | 65.5 | 83.4 | 45.0 | | | 202.5 | 90.3 | |

| Depreciation (Cr) | 120.7 | 100.8 | 66.1 | | | 283.2 | 177.2 | |

| Exceptional items (Cr) | | -13.2 | -0.3 | | | -11.2 | 10.8 | |

| Share of profit from associate (Cr) | 0.7 | 1.0 | - | | | 2.6 | - | |

| Reported EBITDA (Cr) | 278.9 | 239.8 | 208.2 | 16.3% | 34.0% | 828.2 | 814.8 | 1.6% |

| INDAS (Cr) | 28.7 | 17.7 | 7.5 | | | 43.6 | 23.9 | |

| EBITDA Pre INDAS & Excl.Other Income (Cr) | 231.6 | 205.7 | 196.5 | 12.6% | 17.9% | 758.4 | 759.0 | -0.1% |

| EBITDA % to Revenue | 17.2% | 17.4% | 20.5% | | | 19.4% | 25.0% | |

*PBT inclusive of gain on fair valuation of call option, Statutory impact of new Labor Codes and Share of profit from associate

Operational Highlights

Q2 FY27 Operational Metrics:

  • ARPOB (Average Revenue Per Occupied Bed): INR 48,277 (14.9% YoY growth, 2.3% QoQ growth)
  • ARPP (Average Revenue Per Patient): INR 1,65,577 (9.9% YoY growth, 1.2% QoQ growth)

Operational Metrics Table:

| Particulars | Q2 FY27 | Q1 FY27 | Q2 FY26 | QoQ | YoY | FY26 | FY25 | YoY |

| IP Volume | 81,668 | 72,493 | 64,288 | 12.7% | 27.0% | 2,46,297 | 2,13,346 | 15.4% |

| OP Volume | 7,31,010 | 6,58,617 | 5,92,725 | 11.0% | 23.3% | 23,00,360 | 18,34,312 | 25.4% |

| ARPOB (Rs) | 48,277 | 47,200 | 42,016 | 2.3% | 14.9% | 44,644 | 39,158 | 14.0% |

| ARPP (Rs) | 1,65,577 | 1,63,573 | 1,50,624 | 1.2% | 9.9% | 1,59,575 | 1,43,293 | 11.4% |

Clinical Achievements Highlights

The press release detailed numerous complex clinical cases successfully treated across KIMS hospital network:

KIMS Secunderabad:

  • Saved 32-year-old woman with severe ARDS using ECMO support and critical care
  • Performed hip surgery on 100-year-old female patient with exceptional recovery
  • Treated rare intestinal cancer in 42-year-old woman while preserving transplanted kidney
  • Managed high-risk pregnancy with laparoscopic trans-abdominal cerclage
  • Reached milestone of 300 Robotic surgeries on Davinci XI system

KIMS Kondapur:

  • Performed rare complex aortic reconstruction with suspended animation
  • Removed rare functioning paraganglioma tumor encasing major blood vessels
  • Treated Budd-Chiari syndrome with angioplasty and stenting, avoiding liver transplant
  • Treated subglottic stenosis in 28-day-old infant with specialized balloon dilation

KIMS Gachibowli:

  • Performed robotic-assisted mitral valve replacement on 37-year-old patient

KIMS Icon - Visakhapatnam:

  • Performed first-ever awake brain tumour surgery on 25-year-old woman

KIMS Seethammadhara - Visakhapatnam:

  • Performed mechanical thrombectomy on 9-month pregnant woman with ischemic stroke
  • Removed 6 cm esophageal tumor using Third Space Endoscopy without external incision
  • Treated rare giant brain aneurysm using minimally invasive endovascular procedure

KIMS Savera - Anantapur:

  • Treated hepatocellular carcinoma with TACE procedure
  • Performed emergency angioplasty on 90-year-old heart attack survivor with CKD
  • Treated severe heart attack with OCT-guided stenting, avoiding bypass surgery
  • Treated brain aneurysm with endovascular coiling
  • Performed Rayalaseema's first emergency rigid bronchoscopy with metallic Y-stent placement

KIMS Kurnool:

  • Treated 22-month-old baby with rare gastric volvulus
  • Treated 8-year-old boy with snake bite induced kidney failure
  • Performed complex eyelid reconstruction on 6-year-old girl

KIMS Bengaluru:

  • Administered first infusion of DONANEMAB for early Alzheimer's disease treatment

Management Commentary

Dr. B Bhaskara Rao, CMD, KIMS Hospitals stated: "Q2 FY 27 and H1FY27 have been exceptionally good for us on multiple fronts. We added our 3rd hospital in Palakkad, Kerala. I am particularly happy to see our newer units of Bengaluru and Thane doing advanced clinical work including lung transplants. Our overall footfalls to both OP and IP have shown healthy uptrend which has also been translated in a healthy topline and bottom line. We remain confident of achieving the milestones set for the second half of FY 27."

Company Overview

KIMS Hospitals operates 29 hospitals with over 9,300+ beds across Telangana, Andhra Pradesh, Karnataka, Kerala, and Maharashtra, with plans to add more than 700+ beds through upcoming projects taking the bed capacity to 10,000+. Organ transplantations are performed across all 10 KIMS hospitals in Andhra Pradesh.